Azithromycin NDC 85766-008

NDC codes

FDA NDC Directory

Product NDC (as listed)85766-008Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85766-0008Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85766-008-06	85766000806	6 DOSE PACK in 1 CARTON (85766-008-06) / 1 TABLET, FILM COATED in 1 DOSE PACKMarketed from Jun 18, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Azithromycin
Generic name (nonproprietary): azithromycin
Active ingredients: Azithromycin dihydrate — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sportpharm LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065211
Marketing start: Nov 14, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Macrolides (Chemical structure)
Identifiers: Product ID 85766-008_49eeafc2-f6d5-2cfd-e063-6394a90a7af6SPL ID 49eeafc2-f6d5-2cfd-e063-6394a90a7af6SPL set ID 60ec2020-148b-4a2a-96f2-dd09c590ecbbRxCUI 308460, 749783UNII 5FD1131I7S
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485766000806 followed by a unit qualifier and the quantity

Package 85766-0008-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 3, 2026.

Indications (excerpt from the label)

Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications [see Dosage and Administration ( 2 )]. Azithromycin tablets are a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: Acute bacterial exacerbations of chronic bronchitis in adults ( 1.1 ) Acute bacterial sinusitis in adults ( 1.1 ) Uncomplicated skin and skin structure infections in adults ( 1.1 ) …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065211

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065211
Product	Strength	Form · route	Labeler	Product NDC
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8124
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Proficient Rx LP	71205-645
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Sandoz Inc	0781-8089
Azithromycin	Azithromycin dihydrate 250 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-213